Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(10 sites)
United States
Loma Linda University Cancer Center, Loma Linda, California Hoag Memorial Hospital Presbyterian, Newport, California SHARP Healthcare, San Diego, California Miami Cancer Institute at Baptist Health, Miami, Florida Hope and Healing Cancer Services, Hinsdale, Illinois Trinity Health, Ypsilanti, Michigan Cleveland Clinic, Cleveland, Ohio Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania Vanderbilt University Medical Center, Nashville, Tennessee Doctors Hospital of Laredo, Laredo, Texas